Secosteroid thiosemicarbazides and secosteroid-1,2,4-triazoles as antiproliferative agents targeting breast cancer cells: Synthesis and biological evaluation

J Steroid Biochem Mol Biol. 2023 Nov:234:106386. doi: 10.1016/j.jsbmb.2023.106386. Epub 2023 Sep 2.

Abstract

A convenient and selective approach to 13,17-secoestra-1,3,5(10)-trien-17-oic acid [N'-arylcarbothioamido]hydrazides and hybrid molecules containing secosteroid and 1,2,4-triazole fragments was disclosed and these novel types of secosteroids were screened for cytotoxicity against hormone-dependent human breast cancer cell line MCF-7. Most of secosteroid-1,2,4-triazole hybrids showed significant cytotoxic effect comparable or superior to that of the reference drug cisplatin. Hit secosteroid-1,2,4-triazole hybrids 4b and 4h were characterized by high cytotoxicity and good selectivity towards MCF-7 breast cancer cells. PARP cleavage (marker of apoptosis) and ERα and cyclin D1 downregulation were discovered in MCF-7 cells treated with lead secosteroid-1,2,4-triazole hybrid 4b. The synthesized secosteroids may be considered as new promising anticancer agents.

Keywords: 1; 2; 4-Triazoles; Breast cancer; Cytotoxicity; Hydrazides; Secosteroids; Thiosemicarbazides.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Breast Neoplasms* / drug therapy
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • MCF-7 Cells
  • Molecular Structure
  • Structure-Activity Relationship
  • Triazoles / pharmacology

Substances

  • thiosemicarbazide
  • Triazoles
  • Antineoplastic Agents